Friedman E, Shadel M, Halkin H, Farfel Z
Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Ann Intern Med. 1989 Jan 1;110(1):24-30. doi: 10.7326/0003-4819-110-1-24.
To determine whether a single-dose of thiazide administered to patients with previous thiazide-induced hyponatremia will cause hyponatremia and, if so, to analyze its pathogenesis.
Prospective controlled study comparing patients with previous thiazide-induced hyponatremia with two control groups.
Eleven patients with thiazide-induced (Kaluril [hydrochlorothiazide, 50 mg; amiloride, 5 mg]) hyponatremia of less than 130 mmol/L at least 1 week before the study. Two groups of controls: 10 young healthy volunteers and 11 elderly hypertensive patients previously treated uneventfully with thiazide.
Administration of a single dose of hydrochlorothiazide, 50 mg, and amiloride, 5 mg.
Blood pressure, pulse rate, body weight, serum urea, creatinine, sodium, potassium, magnesium, osmolality, plasma antidiuretic hormone, renin, aldosterone and also urinary sodium, potassium, osmolality, and cyclic adenosine monophosphate (cAMP) before and 6 to 8, 12, and 24 hours after drug administration.
Within 6 to 8 hours serum sodium decreased in patients, young controls, and elderly controls by 5.5 +/- 1.1 (mean +/- SE), 1.2 +/- 0.4, and 1.8 +/- 0.9 mmol/L, respectively (Py less than 0.001 [patients versus young controls], Pe = 0.017 [patients versus elderly controls]). Serum osmolality decreased in patients, young controls, and elderly controls by 14.9 +/- 2.6, 2.8 +/- 1.6, and 6.6 +/- 1.5 mmol/kg, respectively (Py less than 0.001, Pe = 0.012). All patients and only one control subject reached osmolality of less than 280 mmol/kg. At 6 to 8 hours all patients gained weight (0.85 +/- 0.13 kg) whereas young and elderly controls lost weight (0.47 +/- 0.23 and 0.45 +/- 0.2 kg, respectively) (Py much less than 0.001, Pe much less than 0.001). Patients' responses to the drug did not differ from both control groups regarding sodium and potassium urinary excretion, osmolar and free water clearance, and antidiuretic hormone blood levels. Water restriction in one patient attenuated serum sodium reduction.
Use of a single-dose of a thiazide diuretic may predict the development of hyponatremia. Increased body weight apparently due to polydipsia may play a major role in the pathogenesis of thiazide-induced hyponatremia.
确定对曾因噻嗪类药物导致低钠血症的患者给予单剂量噻嗪类药物是否会引发低钠血症,若会引发,则分析其发病机制。
前瞻性对照研究,将曾因噻嗪类药物导致低钠血症的患者与两个对照组进行比较。
11例曾因服用卡鲁利(氢氯噻嗪50毫克;阿米洛利5毫克)导致低钠血症且血钠浓度低于130 mmol/L至少1周的患者,研究前至少1周。两组对照组:10名年轻健康志愿者和11名此前使用噻嗪类药物治疗平稳的老年高血压患者。
给予单剂量50毫克氢氯噻嗪和5毫克阿米洛利。
给药前及给药后6至8小时、12小时和24小时的血压、脉搏率、体重、血清尿素、肌酐、钠、钾、镁、渗透压、血浆抗利尿激素、肾素、醛固酮,以及尿钠、钾、渗透压和环磷酸腺苷(cAMP)。
在6至8小时内,患者、年轻对照组和老年对照组的血清钠分别下降了5.5±1.1(均值±标准误)、1.2±0.4和1.8±0.9 mmol/L(患者与年轻对照组相比,P<0.001;患者与老年对照组相比,Pe = 0.017)。患者、年轻对照组和老年对照组的血清渗透压分别下降了14.9±2.6、2.8±1.6和6.6±1.5 mmol/kg(患者与年轻对照组相比,P<0.001;患者与老年对照组相比,Pe = 0.012)。所有患者及仅1名对照受试者的渗透压降至低于280 mmol/kg。在6至8小时时,所有患者体重增加(0.85±0.13千克),而年轻和老年对照组体重减轻(分别为0.47±0.23千克和0.45±0.2千克)(患者与年轻对照组相比,P<<0.001;患者与老年对照组相比,Pe<<0.001)。患者对药物的反应在尿钠和钾排泄、渗透和自由水清除率以及抗利尿激素血水平方面与两个对照组无差异。1例患者限水后血清钠降低幅度减小。
使用单剂量噻嗪类利尿剂可能预示低钠血症的发生。明显因多饮导致的体重增加可能在噻嗪类药物所致低钠血症的发病机制中起主要作用。